Recombinant Human IL17B Protein，His

Interleukin-17B (IL-17B) is a member of the IL-17 cytokine family, known for its roles in immune response and inflammation. Initially discovered for its similar structure to other IL-17 family members, IL-17B has gained attention due to its involvement in various physiological and pathological processes. Research indicates that IL-17B is produced by different cell types, including T cells and epithelial cells, and plays a significant role in mediating inflammation and immune responses in numerous diseases, including autoimmune disorders, cancer, and infections. Recent studies have shown that IL-17B can influence the behavior of various immune cell types, enhancing the understanding of its function in tumor microenvironments and chronic inflammatory conditions. Importantly, IL-17B's receptor, IL-17RB, has been implicated in signaling pathways that promote cell survival, proliferation, and the release of pro-inflammatory cytokines. This has established IL-17B as a potential therapeutic target for modulating immune responses. As research progresses, the development of recombinant IL-17B proteins for experimental use may provide valuable insights into its biological functions and therapeutic potential, paving the way for novel treatment strategies for diseases driven by dysregulated immune responses. Understanding the precise mechanisms of IL-17B action could contribute significantly to the field of immunology and open avenues for innovative therapeutic approaches aimed at manipulating immune responses for better clinical outcomes.